Biplane — Neurointervention index

Neurointervention Reference

Clinical evidence, devices, and trials at the point of care.

Clinical guidelines, device mechanics, and weekly literature curated for the neurointerventional suite.

Large Cores, Distal Vessels, Rural Reach

1 / 3

01In GSR-ET, 90-day mRS 0–3 was 20.2% with ASPECTS 1–2 (n=89) versus 28.5% with ASPECTS 3–5; adjusted common OR 0.80 (0.53–1.23), not significant.
02In a post hoc DISTAL analysis, patients predicted to do well on medical treatment alone had worse 90-day mRS with thrombectomy: common OR 0.48 (0.27–0.84).
03In a retrospective TEMPiS cohort of 492 patients, median decision-to-groin time was 69 minutes with a flying intervention team versus 140 with transfer; ordinal 90-day mRS did not differ significantly.

04In a propensity-matched VQI registry analysis of non-atherosclerotic carotid disease, stroke or death was 1.9% with TCAR versus 7.6% with transfemoral stenting.
05In retrospective TriNetX data on chronic subdural haematoma with platelets below 100, MMA embolisation was associated with lower 90-day mortality than medical management: HR 0.65 (0.50–0.85).

Materials & devices

Product specifications, manufacturer links and side-by-side comparison — with coaxial sizing for the complete system.

—devices

—device classes

The Evidence Library

Guidelines, trials, registries, reviews and recorded cases — each linked to the original publication.

495entries

23conditions

01In GSR-ET, 90-day mRS 0–3 was 20.2% with ASPECTS 1–2 (n=89) versus 28.5% with ASPECTS 3–5; adjusted common OR 0.80 (0.53–1.23), not significant.
02In a post hoc DISTAL analysis, patients predicted to do well on medical treatment alone had worse 90-day mRS with thrombectomy: common OR 0.48 (0.27–0.84).
03In a retrospective TEMPiS cohort of 492 patients, median decision-to-groin time was 69 minutes with a flying intervention team versus 140 with transfer; ordinal 90-day mRS did not differ significantly.
04In a propensity-matched VQI registry analysis of non-atherosclerotic carotid disease, stroke or death was 1.9% with TCAR versus 7.6% with transfemoral stenting.
05In retrospective TriNetX data on chronic subdural haematoma with platelets below 100, MMA embolisation was associated with lower 90-day mortality than medical management: HR 0.65 (0.50–0.85).